Processa Pharmaceuticals Inc (NASDAQ: PCSA) kicked off on Monday, up 30.86% from the previous trading day, before settling in for the closing price of $0.21. Over the past 52 weeks, PCSA has traded in a range of $0.15-$1.50.
A company in the Healthcare sector has jumped its sales by 22.65% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 88.37%. With a float of $43.77 million, this company’s outstanding shares have now reached $50.35 million.
Processa Pharmaceuticals Inc (PCSA) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Processa Pharmaceuticals Inc is 13.07%, while institutional ownership is 0.74%. The most recent insider transaction that took place on Jan 27 ’25, was worth 9,889. In this transaction Director of this company bought 12,400 shares at a rate of $0.80, taking the stock ownership to the 12,400 shares. Before that another transaction happened on Jan 27 ’25, when Company’s Chief Executive Officer bought 87,200 for $0.80, making the entire transaction worth $69,542. This insider now owns 87,200 shares in total.
Processa Pharmaceuticals Inc (PCSA) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -1.03 earnings per share (EPS), lower than consensus estimate (set at -1) by -0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 88.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 59.35% during the next five years compared to 22.65% growth over the previous five years of trading.
Processa Pharmaceuticals Inc (NASDAQ: PCSA) Trading Performance Indicators
Take a look at Processa Pharmaceuticals Inc’s (PCSA) current performance indicators. Last quarter, stock had a quick ratio of 3.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.32, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of Processa Pharmaceuticals Inc (PCSA)
Let’s dig in a bit further. During the last 5-days, its volume was 10.86 million. That was better than the volume of 7.95 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 63.34%.
During the past 100 days, Processa Pharmaceuticals Inc’s (PCSA) raw stochastic average was set at 19.36%, which indicates a significant decrease from 86.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0211 in the past 14 days, which was lower than the 0.0347 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2089, while its 200-day Moving Average is $0.3811. However, in the short run, Processa Pharmaceuticals Inc’s stock first resistance to watch stands at $0.3121. Second resistance stands at $0.3453. The third major resistance level sits at $0.3975. If the price goes on to break the first support level at $0.2267, it is likely to go to the next support level at $0.1745. The third support level lies at $0.1413 if the price breaches the second support level.
Processa Pharmaceuticals Inc (NASDAQ: PCSA) Key Stats
The company with the Market Capitalisation of 14.04 million has total of 50,349K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -11,850 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -3,930 K.
